Landscape of CDK4/6 inhibitors Clinical experience, efficacy and side effect management
Härmed inbjuds du till att delta vid ett direktsänt och interaktivt webinar
We are pleased to invite you to Lilly Academy, an interactive education on metastatic breast cancer. The focus for this session will be a look into CDK4/6 inhibitors – discussing clinical experience, efficacy and side effect management. All participants are welcome to submit questions prior to the lecture through your local contact from Lilly or via the chat function during the meeting. The meeting will be held in English.